Sakar Healthcare Ltd SAKAR
NSE · India · Health Technology
INR 1,075.00-18.05 (-1.65%)
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Strong Q1 FY27 results showcase 38% revenue growth and a robust oncology pipeline, with management guiding toward a significant export-led acceleration in the coming quarters.
Sakar Healthcare Ltd (NSE:SAKAR) reports a robust 62% revenue increase and significant strides in its oncology segment, despite facing regulatory and cost challenges.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.